$17.17
0.12 (+0.70%)
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)
CAPS Rating:
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
RSS Headlines
Fool UK
Recs
I love the biotechs,but there Is heavy insider selling here... TS